Net Cash Provided by (Used in) Operating Activities |
283K |
USD |
|
Q4 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
156K |
USD |
|
Q4 2024 |
Q1 2025 |
Common Stock, Shares Authorized |
500M |
shares |
0% |
Q1 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
12M |
shares |
0% |
Q1 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q1 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
439K |
USD |
|
Q4 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
634K |
USD |
+410% |
Q1 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
0 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
6.84K |
USD |
|
Q3 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
6.84K |
USD |
|
Q3 2024 |
FY 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
943K |
USD |
|
Q1 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid |
108K |
USD |
|
Q1 2025 |
Q2 2025 |
Operating Lease, Liability, Current |
61.1K |
USD |
|
Q1 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year Two |
64.8K |
USD |
|
Q1 2025 |
Q2 2025 |
Lessee, Operating Lease, Liability, to be Paid, Year One |
43.2K |
USD |
|
Q1 2025 |
Q2 2025 |
Operating Lease, Weighted Average Discount Rate, Percent |
0.05 |
pure |
|
Q1 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
6.84K |
USD |
|
Q3 2024 |
FY 2024 |
Deferred Federal Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2023 |
Q1 2024 |
Current Income Tax Expense (Benefit) |
469 |
USD |
|
Q4 2023 |
Q1 2024 |
Additional Paid in Capital |
139K |
USD |
0% |
Q1 2025 |
Q2 2025 |
Current State and Local Tax Expense (Benefit) |
208 |
USD |
|
Q4 2023 |
Q1 2024 |
Current Federal Tax Expense (Benefit) |
261 |
USD |
|
Q4 2023 |
Q1 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
0 |
USD |
|
Q3 2024 |
FY 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
0 |
USD |
|
Q4 2023 |
Q1 2024 |